Inhibitory receptor expression post-HSCT
| . | Ratio R/D . | ||
|---|---|---|---|
| D30 . | D60 . | D100 . | |
| KIR2DL1 | 0.28 ± 0.18 | 0.46 ± 0.29 | 0.59 ± 0.44 |
| KIR2DL2/3 | 1.26 ± 0.50 | 1.40 ± 0.37 | 1.57 ± 1.03 |
| KIR3DL1 | 1.31 ± 0.85 | 1.60 ± 0.57 | 1.49 ± 0.89 |
| . | Ratio R/D . | ||
|---|---|---|---|
| D30 . | D60 . | D100 . | |
| KIR2DL1 | 0.28 ± 0.18 | 0.46 ± 0.29 | 0.59 ± 0.44 |
| KIR2DL2/3 | 1.26 ± 0.50 | 1.40 ± 0.37 | 1.57 ± 1.03 |
| KIR3DL1 | 1.31 ± 0.85 | 1.60 ± 0.57 | 1.49 ± 0.89 |
R indicates the percentage of NK cells positive for the inhibitory receptor in the recipient at days +30, +60, and +100 after HSCT; D, the percentage of NK cells positive for the inhibitory receptor in the donor; and Ratio R/D, the ratio calculated for each recipient/donor pair (n=16).